| 65.17 |  -0.04 / -0.06% |
Data as of 4:00pm ET | Day’s Change |
| 65.17 |  0.00 / 0.00% |
Volume: 1.9K |
| St. Jude Begins EnligHTNment Study - Analyst Blog 2:29pm / Zacks.com | Covidien Prices Senior Notes - Analyst Blog May 16 / Zacks.com |
| Covidien's ENB Adopted by ACCP - Analyst Blog May 23 / Zacks.com | Masimo Wins a Major Turkish Client - Analyst Blog May 13 / Zacks.com |
| FDA Nod for COV's Advanced Nellcor - Analyst Blog May 21 / Zacks.com |
| Previous close | 65.21 |
| Today’s open | 64.99 |
| Day’s range | 64.57 - 65.62 |
| Volume | 1,800,414 |
| Average volume (3 months) | 2,530,110 |
| Market cap | $30.7B |
| Dividend yield | 1.60% |
| Earnings growth (last year) | +3.66% |
| Earnings growth (this year) | +3.37% |
| Earnings growth (next 5 years) | +8.50% |
| Revenue growth (last year) | +2.40% |
| P/E ratio | -- |
| Price/Sales | 2.41 |
| Price/Book | 2.91 |
| Today’s change | Today’s % change | |
|---|---|---|
| SYKStryker Corp | -0.25 | -0.37% |
| BDXBecton Dickinson and... | +0.66 | +0.66% |
| ZMHZimmer Holdings Inc | -0.08 | -0.10% |
| BSXBoston Scientific Co... | -0.08 | -0.87% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.11 |
| Annual revenue (last year) | $11.9B |
| Annual profit (last year) | $1.9B |
| Net profit margin | 16.05% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President & Chief Executive Officer José E. Almeida |
Senior Vice President-Quality & Operations Michael Sgrignari |
Corporate headquarters Dublin, Dublin |
.
